Abstract:Osteoporosis is a common systemic metabolic disease characterized by a decrease in bone density and bone mass, destruction of bone tissue microstructure, and increased bone fragility leading to fracture susceptibility. Pharmacological treatment of osteoporosis is the focus of current research, and anti-osteoporosis drugs usually play a role in inhibiting bone resorption, promoting bone formation, and having a dual role. However, most of the drugs have the disadvantages of single target and high toxic and side effects. There are many types of traditional Chinese medicines (TCM), from a wide range of sources and mostly plants. Herbal plants have unique advantages in regulating the relationship between osteoporosis and the immune system, acupuncture therapy has significant therapeutic effects in combination with medicine for osteoporosis. The target cells and specific molecular mechanisms of TCM in preventing and treating osteoporosis have not been fully elucidated. At present, there is a lack of comprehensive understanding of the pathological mechanism of the disease. Therefore, a better understanding of the pathological signaling pathways and key molecules involved in the pathogenesis of osteoporosis is crucial for the design of therapeutic targets and drug development. In this paper, we review the development and current status of anti-osteoporosis drugs currently in clinical application and under development to provide relevant basis and reference for drug prevention and treatment of osteoporosis, with the aim of promoting pharmacological research and new drug development.

Research progress of osteoporosis drug treatment

Research and Application of Target Therapy for Osteoporosis

Advances in nutritional intervention of osteoporosis

Therapeutic progress of postmenopausal osteoporosis

Osteoporosis treatment: current drugs and future developments

Advances in Our Understanding of the Mechanism of Action of Drugs (including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis

Synthesis and biological activities of drugs for the treatment of osteoporosis

Recent Progresses in the Treatment of Osteoporosis

Research progress of denosumab in treatment of osteoporosis

Research progress of growth hormone in the treatment of osteoporosis in senile male patients

Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review

Research Progress in Osteoporotic Fracture

Drug Delivery and Therapy Strategies for Osteoporosis Intervention

Advances in Pathogenesis and Therapeutic Strategies for Osteoporosis

Recent advance of small-molecule drugs for clinical treatment of osteoporosis: A review

Anti-inflammatory and antioxidant traditional Chinese Medicine in treatment and prevention of osteoporosis

Research progress of effects of anti-osteoporosis drugs on osteoporotic fractures

Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions

Research progress in prevention and disease management of osteoporotic fractures

Research Progress of Chinese Medicine in Treatment of Osteoporosis

Trends in Antiosteoporosis Use in Nine Major Areas In China younger than 50 years old From 2016 to 2019